---
figid: PMC3368374__IJE2012-127362.001
figlink: /pmc/articles/PMC3368374/figure/fig1/
number: F1
caption: (a) In young muscle, abundant serum IGF-I can stimulate protein synthesis
  by activating Akt/mTOR/p70S6K pathway. Akt blocks the nuclear translocation of FOXO
  to inhibit the expression of Atrogin-1 and MuRF and the consequent protein degradation.
  Abundant serum GH, which is induced by ghrelin, activates JAK2-STAT5 signaling to
  promote muscle-specific gene transcription necessary to hypertrophy. In young muscle,
  testosterone and estrogen bind these intramuscular receptors (androgen receptor
  and estrogen receptor (α and β)), and activate mTOR and Akt, respectively. Lower
  serum amount of myostatin and TNF-α failed to activate signaling candidates (Smad
  2/3, NF-κB, etc.) enhancing protein degradation. (b) In sarcopenic muscle, myostatin
  signals through the activin receptor IIB (ActRIIB), ALK4/5 heterodimer seems to
  activate Smad2/3 and blocking of MyoD transactivation in an autoregulatory feedback
  loop. Abundant activated Smad2/3 inhibit protein synthesis probably due to blocking
  the functional role of Akt. The increased blood TNF-α elevates the protein degradation
  through IKK/NF-κB signaling and enhance an apoptosis. Lower serum amount of IGF-I,
  GH, and anabolic hormones (testosterone and estrogen) failed to activate signaling
  candidates (Akt, mTOR, STAT5, etc.) enhancing protein synthesis. The impaired regulation
  of FOXO by Akt results in abundant expression of Atrogin-1 and MuRF and the consequent
  protein degradation in sarcopenic muscle.
pmcid: PMC3368374
papertitle: Sarcopenia and Age-Related Endocrine Function.
reftext: Kunihiro Sakuma, et al. Int J Endocrinol. 2012;2012:127362.
pmc_ranked_result_index: '25419'
pathway_score: 0.8794806
filename: IJE2012-127362.001.jpg
figtitle: In young muscle, abundant serum IGF-I can stimulate protein synthesis by
  activating Akt/mTOR/p70S6K pathway
year: '2012'
organisms: Homo sapiens
ndex: f1ff9c29-df11-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3368374__IJE2012-127362.001.html
  '@type': Dataset
  description: (a) In young muscle, abundant serum IGF-I can stimulate protein synthesis
    by activating Akt/mTOR/p70S6K pathway. Akt blocks the nuclear translocation of
    FOXO to inhibit the expression of Atrogin-1 and MuRF and the consequent protein
    degradation. Abundant serum GH, which is induced by ghrelin, activates JAK2-STAT5
    signaling to promote muscle-specific gene transcription necessary to hypertrophy.
    In young muscle, testosterone and estrogen bind these intramuscular receptors
    (androgen receptor and estrogen receptor (α and β)), and activate mTOR and Akt,
    respectively. Lower serum amount of myostatin and TNF-α failed to activate signaling
    candidates (Smad 2/3, NF-κB, etc.) enhancing protein degradation. (b) In sarcopenic
    muscle, myostatin signals through the activin receptor IIB (ActRIIB), ALK4/5 heterodimer
    seems to activate Smad2/3 and blocking of MyoD transactivation in an autoregulatory
    feedback loop. Abundant activated Smad2/3 inhibit protein synthesis probably due
    to blocking the functional role of Akt. The increased blood TNF-α elevates the
    protein degradation through IKK/NF-κB signaling and enhance an apoptosis. Lower
    serum amount of IGF-I, GH, and anabolic hormones (testosterone and estrogen) failed
    to activate signaling candidates (Akt, mTOR, STAT5, etc.) enhancing protein synthesis.
    The impaired regulation of FOXO by Akt results in abundant expression of Atrogin-1
    and MuRF and the consequent protein degradation in sarcopenic muscle.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - ACVR1B
  - TSC2
  - ACVR2B
  - SMAD3
  - SMAD2
  - AKT2
  - GHRL
  - IGF1R
  - AKT3
  - TNF
  - TGFBR1
  - NFKB1
  - IGF1
  - RHEB
  - GGH
  - FOXO3
  - TRIM54
  - CHUK
  - FOXO4
  - FBXO32
  - MYOD1
  - FOXO6
  - IKBKG
  - FOXO1
  - JAK2
  - IKBKB
  - MTOR
  - Androgen
  - Estrogen
  - O Estrogen
  - Testosterone
  - Cancer
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ALK4/5
  symbol: ALK4
  source: hgnc_alias_symbol
  hgnc_symbol: ACVR1B
  entrez: '91'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: ActRIIB
  symbol: ActR-IIB
  source: hgnc_alias_symbol
  hgnc_symbol: ACVR2B
  entrez: '93'
- word: P-Smad2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: P-Smad2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Ghrelin
  symbol: ghrelin
  source: hgnc_alias_symbol
  hgnc_symbol: GHRL
  entrez: '51738'
- word: IGF-IR
  symbol: IGFIR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: ALK4/5
  symbol: ALK-5
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: GGH
  symbol: GGH
  source: hgnc_symbol
  hgnc_symbol: GGH
  entrez: '8836'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: MuRF
  symbol: MURF
  source: hgnc_alias_symbol
  hgnc_symbol: TRIM54
  entrez: '57159'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: Atrogin-1
  symbol: ATROGIN1
  source: hgnc_alias_symbol
  hgnc_symbol: FBXO32
  entrez: '114907'
- word: MyoD
  symbol: MYOD
  source: hgnc_alias_symbol
  hgnc_symbol: MYOD1
  entrez: '4654'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals:
- word: Androgen
  source: MESH
  identifier: D000728
- word: Estrogen
  source: MESH
  identifier: D004967
- word: O Estrogen
  source: MESH
  identifier: D004967
- word: Testosterone
  source: MESH
  identifier: D013739
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3368374__F1
redirect_from: /figures/PMC3368374__F1
figtype: Figure
---
